BCLSI
Bain Capital Life Sciences Investors Portfolio holdings
AUM
$799M
This Quarter Return
-8.52%
1 Year Return
+36.47%
3 Year Return
+278.05%
5 Year Return
+363.53%
10 Year Return
–
AUM
$853M
AUM Growth
+$853M
(-17%)
Cap. Flow
+$30.3M
Cap. Flow
% of AUM
3.56%
Top 10 Holdings %
Top 10 Hldgs %
71.46%
Holding
37
New
3
Increased
4
Reduced
2
Closed
2
Top Buys
| 1 |
TVRD
Tvardi Therapeutics, Inc. Common Stock
TVRD
|
$24.2M |
| 2 |
Protagonist Therapeutics
PTGX
|
$17.9M |
| 3 |
Mersana Therapeutics
MRSN
|
$9.89M |
| 4 |
Acadia Pharmaceuticals
ACAD
|
$8.46M |
| 5 |
Nurix Therapeutics
NRIX
|
$6.82M |
Top Sells
| 1 |
Arcutis Biotherapeutics
ARQT
|
$20.9M |
| 2 |
Amylyx Pharmaceuticals
AMLX
|
$15.6M |
| 3 |
OMEG
Omega Alpha SPAC Class A Ordinary Shares
OMEG
|
$3.93M |
| 4 |
JYAC
Jiya Acquisition Corp. Class A Common Stock
JYAC
|
$2.95M |
Sector Composition
| 1 | Healthcare | 95.18% |
| 2 | Financials | 3.66% |
